Use of Octreotide in Chylothorax With Mediastinal Mass of Unknown Behaviour: A Case Report. [PDF]
Respirol Case RepA 37‐year‐old woman with chylothorax and a mediastinal mass of uncertain behaviour had persistent pleural drainage despite initial interventions and unavailable advanced options. Octreotide infusion resulted in a marked reduction of drainage and complete resolution.
Geronimo AJ, Monis M.
europepmc +2 more sources
Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study [PDF]
Journal of Experimental & Clinical Cancer Research, 2009 Background Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched ...
Müller Christian +3 more
doaj +2 more sources
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological Diseases. [PDF]
Liver IntABSTRACT Polycystic liver disease (PLD) is a rare genetic disorder characterised by progressive liver enlargement due to multiple cysts. The main symptoms are liver volume‐related. Although randomised controlled trials have shown that somatostatin analogues (SSAs) reduce liver volume as well as symptoms, specific guidance on when and how to use SSAs in
Heinrich S +16 more
europepmc +2 more sources
BMC Endocrine Disorders, 2023 Background To prevent thyroid storm and ensure surgical safety, it is imperative to regulate excessive thyroid hormone levels in patients with thyrotropin-secreting pituitary adenomas (TSHoma) prior to surgery.
Runsheng Zhao, Kaiyu Fan, Weiqing Wan
doaj +1 more source
The effect of SRIH-14 or octreotide on the morphological characteristics of adrenal medulla using newcast [PDF]
Archives of Biological Sciences, 2010 The effects of chronic treatments with either SRIH-14 or octreotide on the adrenal medulla of male Wistar rats were examined. Adult males received subcutaneous (s.c.) injections of 20 μg/100 g body weight of either SRIH-14 or octreotide twice a day for ...
Trifunović Svetlana +6 more
doaj +1 more source
Trials, 2011 Background Polycystic liver disease (PLD) is defined as having more than 20 liver cysts and can present as a severe and disabling condition. Most symptoms are caused by the mass effect of the liver size and include abdominal pain and distension.
Chrispijn Melissa, Drenth Joost PH
doaj +1 more source
The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells. [PDF]
PLoS ONE, 2012 Octreotide is a widely used synthetic somatostatin analogue that significantly improves the management of neuroendocrine tumours (NETs). Octreotide acts through somatostatin receptors (SSTRs).
Su-Chen Li +8 more
doaj +1 more source
Disrupting cell death: ferroptosis and pyroptosis inhibition in hepatic ischemia-reperfusion injury via modulation of GPX4 and cGAS pathways by deferoxamine and octreotide. [PDF]
Front PharmacolTawfiq RA +3 more
europepmc +3 more sources
Use of Octreotide in the Acute Management of Bleeding Esophageal Varices
Canadian Journal of Gastroenterology, 1997 Acute hemorrhage from esophageal varices is a medical emergency; despite early diagnosis and treatment the associated hospital mortality remains high.
Daniel C Sadowski
doaj +1 more source
Canadian Journal of Gastroenterology, 2004 Intestinal lymphangiectasia, which can be classified as primary or secondary, is an unusual cause of protein-losing enteropathy. The main clinical features include edema, fat malabsorption, lymphopenia and hypoalbuminemia.
S Makhija +4 more
doaj +1 more source